These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1563711)

  • 21. Papillary and follicular thyroid carcinoma: the treatment results of 357 patients at the National Kyushu Cancer Centre of Japan.
    Yasumoto K; Miyagi C; Nakashima T; Baba H; Katsuta Y
    J Laryngol Otol; 1996 Jul; 110(7):657-62. PubMed ID: 8759540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do the prognoses of papillary and follicular thyroid carcinomas differ?
    Donohue JH; Goldfien SD; Miller TR; Abele JS; Clark OH
    Am J Surg; 1984 Jul; 148(1):168-73. PubMed ID: 6742325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Differentiated thyroid carcinoma: prognostic factors].
    Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
    Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors in patients with differentiated thyroid carcinoma.
    Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
    Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor.
    Schelfhout LJ; Creutzberg CL; Hamming JF; Fleuren GJ; Smeenk D; Hermans J; van de Velde CJ; Goslings BM
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):331-7. PubMed ID: 3356216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas.
    Sakamoto A; Kasai N; Sugano H
    Cancer; 1983 Nov; 52(10):1849-55. PubMed ID: 6313176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young.
    Koo JS; Hong S; Park CS
    Thyroid; 2009 Nov; 19(11):1225-31. PubMed ID: 19888860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative histopathological analysis of sporadic pediatric papillary thyroid carcinoma from Japan and Ukraine.
    Bogdanova TI; Saenko VA; Hirokawa M; Ito M; Zurnadzhy LY; Hayashi T; Rogounovitch TI; Miyauchi A; Tronko MD; Yamashita S
    Endocr J; 2017 Oct; 64(10):977-993. PubMed ID: 28794343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The sentinel lymph node in papillary cancer of the thyroid including histological subtype.
    Falvo L; Marzullo A; Palermo S; Biancafarina A; De Stefano M; Vanni B; Sorrenti S; Catania A
    Ann Ital Chir; 2006; 77(1):13-8; discussion 18. PubMed ID: 16910354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
    Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
    Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostically relevant factors in follicular thyroid cancer].
    Böttger T; Klupp J; Sorger K; Junginger T
    Langenbecks Arch Chir; 1990; 375(5):266-71. PubMed ID: 2259260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifocality of thyroid carcinomas: a "privilege" of papillary tumors or not?
    Papageorgiou MS; Liratzopoulos N; Efremidou EI; Karanikas M; Minipoulos G; Manolas KJ
    G Chir; 2010; 31(1-2):20-3. PubMed ID: 20298661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.
    Akslen LA; Varhaug JE
    Cancer; 1995 Nov; 76(9):1643-54. PubMed ID: 8635070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lymph node dissection in non-medullary differentiated thyroid carcinoma].
    Mathonnet M
    Ann Chir; 2006; 131(6-7):361-8. PubMed ID: 16329987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL; Jhiang SM
    Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical treatment of papillary thyroid carcinoma: uni- and multivariate analysis of prognostic factors (TNM staging system included).
    Pelizzo MR; Toniato A; Grigoletto R
    J Exp Clin Cancer Res; 1997 Sep; 16(3):261-5. PubMed ID: 9387899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma.
    Falvo L; Catania A; D'Andrea V; Marzullo A; Giustiniani MC; De Antoni E
    Ann Surg; 2005 Apr; 241(4):640-6. PubMed ID: 15798466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical study on prognostic factors in thyroid carcinoma].
    Tachikawa T; Kumazawa H; Kyomoto R; Yukawa H; Yamashita T; Nishikawa M
    Nihon Jibiinkoka Gakkai Kaiho; 2001 Feb; 104(2):157-64. PubMed ID: 11257780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.